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Isolation and Molecular Characterization of the Human CD34 Gene
By Xing-Yue He, Vincent P. Antao, Desiree Basila, Jeffrey C. Marx, and Brian R. Davis
The human CD34 surface antigen is selectively expressed on hematopoietic stem/ progenitor cells, suggesting that it plays an essential role in early hematopoiesis. Using a 1.5-kb partial human CD34 cDNA sequence, RNA-polymerase chain reaction (PCR), and rapid amplification of cDNA ends (RACE) methods, we cloned and sequenced the full-length (2.65 kb) cDNA. The cDNA encodes a type I transmembrane protein with no obvious homology to other known proteins. The entire CD34 gene of 28 kb was cloned, and the coding sequences mapped to eight exons. Mapping of the 5' termini of mRNAs by 5'-RACE and RNAase protection analyses has HE CD34 ANTIGEN, a molecule of 110 Kd, is ex-T pressed on all measurable hematopoietic stem and progenitor cells.' Purified CD34+ cells are capable of reconstituting the complete hematopoietic system in irradiated primates* and marrow-ablated human^.^ Outside the lymphohematopoietic system, CD34 is expressed only on vascular endothelial c e k 4 Although its restricted distribution encourages the view that it might be involved in stromal-hematopoietic cell interaction, initial experiments were unable to show a role for CD34 antigen in progenitor cell a d h e s i~n .~,~ A 1.5-kb CD34 partial cDNA has recently been isolated by immunoselection (B. Seed, personal communication, March 1990). COS (SV40-transformed African Green Monkey kidney) cells transfected with this cDNA react with anti-CD34 monoclonal antib~dies.~ The predicted amino acid sequence matches that of several peptides derived from the purified CD34 p r~t e i n .~
The cDNA hybridized to a single 2.5-to 2.7-kb RNA species in the immature myelomonocytic line KG-1, its undifferentiated variant KG-la,s and vascular endothelial cells. 4 The single copy CD34 gene has been mapped to chromosome lq.9 TPAinduced differentiation of KG-1 cells resulted in a decreased half-life for CD34 mRNA, suggesting that regulation of CD34 expression may include post-transcriptional mechanism(s).* More recently the murine CD34 gene has been cloned, and significant homology with the human coding sequence identified.l0
In this study, we isolated and sequenced the complete human CD34 cDNA, and cloned and mapped the genomic DNA sequences. In addition, we determined the transcription initiation sites, and identified putative transcriptional regulatory elements. Finally, we compared the human CD34 gene with its murine homologue to identify features which may be important in its function and regulation.
MATERIALS AND METHODS
KG-1, KG-la, K562, and U937 cells were grown as indicated by American Type Culture Collection (Rockville, MD). The A3.01 cell line" was grown in RPMI 1640 media supplemented with 10% fetal bovine serum. CD34+ cells were purified from normal human bone marrow aspirates, after informed consent, by immunomagnetic selection with the My10 anti-CD34 antibody (Becton Dickinson, Mountain View, CA) as described previously.12 Peripheral blood mononuclear cells (PBMCs) were isolated by centrifugation over FicollHypaque (Pharmacia, Piscataway, NJ). RNA was prepared from cells using guanidine thiocyanate/acid-phenol extraction, guanidine thiocyanate/cesium chloride gradient ultracentrifugation, or NP-40 lysis/organic extraction protoc01s.l~ KG-la poly (A)+ RNA was selected from total RNA by affinity chromatography on oligo(dT)-cellulose (Pharma~ia).'~ Gene-specific primers for reverse transcription (RT) and polymerase chain reaction (PCR) were designed from the 1.5-kb partial cDNA sequence kindly provided by B. Seed (Massachusetts General Hospital, Boston); locations of primers are given with respect to our complete cDNA sequence (Fig 1) . Rapid amplification of cDNA ends (RACE)I4 and RT-PCR13 were used to prepare amplified cDNA for cloning. Gel electrophoresis, Southern hybridization, and cloning were performed using standard protocols.13 5'-RACE (pXY5): KG-la poly (A)+ RNA was denatured at 65°C for 5 minutes, placed on ice, and reverse transcribed at 45°C with M-MuLV reverse transcriptase (BRL, Gaithersburg, MD) and primer DBH (467-443, antisense). Excess RT primer was removed, and poly (A) tailing performed with terminal deoxynucleotidyl transferase (Boehringer-Mannheim, Indianapolis, IN). The cDNA pool was amplified in a PCR cocktail12 including (dT)17-adaptor,14 adaptor,14 and DBF( -) (342-318, antisense). The PCR product was digested with Apal (site 297 in cDNA) and Clal (site in adaptor), and cloned into Bluescript M13+ (Stratagene, La Jolla, CA); 15 positive clones were examined.
3'-RACE (pXY3): KG-la poly (A)+ RNA or KG-1 total RNA was reverse transcribed using (dT),,-adaptor14 and M-MuLV RT. The cDNA pool was amplified with primers JM32 (1226-1255, sense) and adaptor primer.14 A 1.5-kb fragment was specifically amplified, gel purified, and cloned into pCRlOOO (Invitrogen, San Diego, CA).
Coding region (pXY6): The oligo (dT) primed cDNA pool was amplified with primers BDl(266-286, sense) and JM31(1424-1395, antisense). A 1.0-kb fragment was specifically amplified, gel purified, blunt ended with Klenow fragment of DNA Polymerase (IBI, New Haven, CT), and cloned into the SmaI site of Bluescript M13+.
Cell source and RNA preparation.
Cloning of CD34 cDNA. Identification of CD34 mRNA in different cell types. Cytoplasmic RNA from KG-1, K.562, U937, and A3.01 cell lines were reverse transcribed with the CD34 gene-specific primer JM31. The cDNA was amplified with CD34 primers JM32 and JM31. After agarose gel electrophoresis and blotting, PCR products were hybridized with CD34 probe JM33 (1341-1312, antisense). Total RNA from bone marrow CD34+ cells and PBMCs were reverse transcribed with oligo(dT) primer. The cDNA was co-amplified for p-actin, using p-actin 5' and 3' primers (Clontech, Palo Alto, CA), and for CD34, using primers BD1 and DBH. After agarose gel electrophoresis and blotting, PCR products were hybridized with CD34 probe A human placental genomic DNA library in AEMBW (Clontech) was probed for CD34 gene sequences with random primer labeled cDNA. Three overlapping A clones were obtained, and their restriction sites mapped by conventional techniq~es.'~ The exon/intron structure of the CD34 gene was obtained by comparative PCR amplification of cDNA and genomic DNA clones using a series of CD34 gene-specific primers (shown schematically in Fig 2A) . An initial set of primers was used to approximately determine the positions of introns by comparing the size of amplified DNA fragments from genomic DNA versus cDNA clones. An additional set of primers was designed and synthesized to more precisely map the exon/ intron boundaries. The positions of the exodintron boundaries are accurate to k25 bp, being determined by the closeness of primers in the vicinity of exodintron boundaries. Individual exons were mapped to the A genomic clones by Southern hybridization with selected CD34 oligonucleotide primers. A 1.5-kb Hind111 (in the flanking cloning site)-EcoRI fragment of clone ADB9 (Fig 2B) , containing exon 1 and 5' flanking sequences, was subcloned into M13mp18 and M13mp19 (Boehringer Mannheim) to give pXYl and pXY2, respectively.
Mapping of the transcription initiation sites by RNAase protection analysis. A 986 bp HindIII-ApaI fragment was excised from the pXY2 clone and cloned into Bluescript M13+ to give pXY4. pXY4 was linearized with Accl and used to generate a 32P-labeled RNA probe using T3 RNA polymerase (Promega, Madison, WI) as described.13 Ribonuclease Protection Assay Kit I1 (Ambion, Aus-DBF( -).
Cloning and mapping the human CD34gene. 
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use only. tin, TX) was used for RNAase protection analysis. After digestion with RNAase, the protected RNA samples were denatured and fractionated on 5% polyacrylamide/b mol/L urea sequencing gels, and subjected to autoradiography.
Sequences of pXY5, pXY6, and pXY3 cDNA clones were obtained using dsDNA and the TaqTrack Sequencing Kit (Promega). pXYl and pXY2 were sequenced using ssDNA and the Sequenase 2.0 Kit (US Biochemical, Cleveland, OH). Except for pXY5, the sequences were confirmed by sequencing the complementary strand. Sequence assembly, and DNA and protein database analyses were performed using the EuGenes sequence analysis program (Release 3.2, Baylor College of Medicine, Houston, TX).
Sequence determination and analyses.
RESULTS
Isolation and sequencing of the complete CD34 cDNA. We have cloned and sequenced the full-length (2.65 kb) cDNA from the CD34+ KG-la cell line. This length is in agreement with the mRNA size identified by Northern analysis? Figure 1A is a diagram of the complete cDNA, together with the three overlapping PCR clones. The cDNA sequence is presented in Fig 1B. The CD34 coding sequence is within one long open reading frame of 373 amino acids. The first methionine in the open reading frame is most consistent with the consensus sequence for initiation of trans1ati0n.l~ On the basis of hydrophobicity analysis, shown in Fig lC, the predicted protein is a type I transmembrane protein with a hydrophobic signal peptide of 19 to 20 amino acids at the amino end, an extracellular domain of 258 residues, a highly hydrophobic transmembrane domain of 21 amino acids, and a hydrophilic cytoplasmic tail of 75 residues. The mature polypeptide has a calculated molecular weight of 37.4 Kd, consistent with the actual 110-Kd protein being heavily glycosylated.7 Nine potential n-glycosylation sites were identified, and o-glycosylation may occur at the numerous serine or threonine residues. Analysis of the amino acid sequence did not show an obvious function for this protein; we found no close homology to any other protein currently in the GenBank database.
The complete CD34 cDNA contains a 5' untranslated region (UTR) of 305 bp and a 1,230-bp 3' UTR. 5'-RACE identified multiple 5' termini for CD34 mRNA (see below). The nucleotide corresponding to the most 5' cDNA end identified by 5' RACE is designated as +1 in Fig 1B. The 5' UTR of this cDNA is extraordinarily long15 with a GC content of 63%. Secondary structure analysis has revealed the possibility of a long hairpin loop structure encompassing the translation start site. Investigation of other genes has suggested that both the length and secondary structure of 5' UTRs affect translational efficiency.I5 Whether these factors affect CD34 translation remains to be determined. mRNA instability has been associated in some genes with multiple ATlTA motifs,16 and secondary str~cture,'~ in the 3' UTRs. Therefore, we examined the 3' UTR for features that could explain the CD34 mRNA instability reported to occur as a result of induced differentiation. 8 We identified only one closely related ATTTITA sequence (1826-1832), and our preliminary analysis showed no significant stemloop structures in the 3' UTR. Further studies will be required to identify the mechanism of post-transcriptional regulation of the CD34 gene.
Pattern of CD34 RNA expression in hematopoietic cells. Figure 3A shows that CD34 mRNA is present in tumor cell lines expressing CD34 surface antigen (KG-1, KG-la), but not in the CD34-negative cell lines (promonocytic U937, erythroleukemic K562, and T-lymphoid A3.01). CD34 mRNA was detected by RT-PCR in 50 CD34+ bone marrow cells, but was undetectable in as many as 8,000 mature peripheral blood cells (Fig 3B) . These data indicate that CD34 mRNA is only present in very immature hematopoietic cells that express the CD34 surface antigen.
Using cDNA probes, we isolated three overlapping genomic DNA A clones that span a total of 38 kb. The exonlintron structure of the CD34 gene was obtained by comparing the ability of numerous primers derived from the CD34 cDNA sequence to amplify CD34 cDNA versus A genomic DNA clones, and hybridizing CD34 oligonucleotide primers to Southern blots of A genomic clones. We have mapped the CD34 gene to 8 exons, as shown in Fig 2A . from the KO-1, U937, K562, and A3.01 tumor cell lines were amplified for CD34-specific sequences with primers JM31 and JM32. After agarose electrophoresis and Southern blotting, the amplified signals were hybridized with an internal CD34 primer JM33. (B) Detection of CD34 mRNA in purified CD34+ bone marrow cells. cDNAs from the following cells were coamplified for p-actin and CD34: CD34+ (purified CD34+ marrow cells), PBMCs (peripheral blood mononuclear cells), KG-la (CD34+ cell line, positive control), and water (negative control). The equivalent cell numbers were as indicated. @Actin cDNA levels were determined by ethidium bromide staining of the agarose gel (upper panel). CD34 cDNA was detected by subsequent blotting, hybridization with probe DBF(-), and autoradiography (lower panel). Primers used for CD34 detection (BD1, DBH) were chosen t o span the large first intron, so that only CD34 mRNA, and not genomic DNA, would be amplified.
which is consistent with the presence of only one major CD34 band in northern blots of KG-1 or KG-la RNA. 252 bp (Fig 1B) and could be segregated into an upstream and downstream cluster. We designated the 5' most cDNA terminus as +1 for presenting the cDNA sequence ( Fig  1B) . RNAase protection analysis (RPA) of KG-la poly (A)+ RNA and KG-1 total RNA confirmed the existence of multiple transcription initiation sites (Fig 4) , and the strongest transcription initiation sites identified by RPA corresponded to the upstream cDNA termini identified by 5'-RACE. RPA also identified additional transcription initiation sites further upstream (10 to 30 bases). Based on the reduced intensity of the larger protected RNA species, these sites appear to be used less frequently. We verified that these upstream transcription initiation sites are in fact used by successfully amplifying the KG-la cDNA pool with primers XYH2 (-17 to -1, sense) and DBH, and subsequent hybridization with BDl (data not shown). Because these primers are located in exon 1 and exon 2, respectively, separated by approximately 8 kb of intron sequences, the signal must have originated from cDNA and not contaminat- use only.
For personal at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From ing genomic DNA. We conclude that the upstream 5'-RACE cDNA termini represent the dominant transcription initiation sites.
In RNAase protection experiments performed with either of two probes (ApaI to AccI, +302 to -345, antisense; or ApaI to SacI, +302 to +89, antisense), we failed to detect significant transcription initiating from within the downstream cluster of 5'-RACE termini (data not shown). These data indicate that either these sites are used infrequently for transcriptional initiation, or the downstream 5' cDNA ends represent premature stops of reverse transcription as mRNA secondary structure was encountered in the 5'-RACE procedure. As indicated above, we have identified a possible stem-loop structure in the CD34 mRNA encompassing the downstream 5' cDNA termini.
Identification of putative transcriptional regulatory elements. Analysis of 666 bp of 5' flanking DNA (Fig 5) showed the absence of the typical promoter motifs, TATA and CAAT. We located three Spl motifs (GGGCGG), two within exon 1 and one at the very start of intron 1. We also identified in the upstream region several potential DNA binding sites for transcription regulatory oncoproteins,ls one myb (TAACTG), one myc (CAAGTG), and six ets-like (AGGAA). The presence of putative regulatory elements and the absence of a splicing acceptor consensus sequence upstream of exon 1 are consistent with our determination of transcription initiation sites.
A comparison of the human and mouse CD34 cDNAs is shown in Fig 6A. The two genes are highly homologous in the protein coding region (human cDNA sequence 306-1424). The carbovl end of the protein, including the cysteine-rich, transmembrane, and cytoplasmic domains, is Homologies between human and mouse CD34 genes.
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For personal at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From most highly conserved. This region is 78% homologous at the amino acid sequence level (data not shown and ref 10) and 77% to 92% similar at the nucleotide level, depending on the domain. The 90% amino acid identity of the cytoplasmic domain strongly suggests that this portion of the protein is important for its function. Both human and mouse cytoplasmic regions contain numerous serines that are potential targets for phosphorylation by protein kinase C.19 The amino end of the CD34 protein, which contains much of the extracellular domain, is far less homologous (37% at the amino acid level, 63% at the DNA sequence level). However, it is perhaps significant that the positions of potential n-glycosylation in this region are quite conserved even in the absence of strong amino acid sequence similarity. This suggests that glycosylation of the extracellular portion of CD34 may be more critical to its function than the specific primary amino acid sequence.
To gain insight into the post-transcriptional regulation of CD34 expression, we compared the untranslated regions of the human and mouse genes and found significant regions of similarity, with 60% to 78% homology. The 5' untranslated regions of both human and mouse CD34 genes have the capacity to form a significant hairpin structure (Fig 1B  and ref 10) . The mouse 3' UTR contains five copies of the ATITA motif,IO which is commonly associated with mRNA instability. 16 We identified only one related ATTTTTA sequence in the human 3' UTR, suggesting that there may be differences in the post-transcriptional regulation of the human and mouse CD34 genes.
The exonlintron structure and genomic map of the human CD34 gene obtained in this study are very similar to those previously obtained for the mouse gene.IO Both genes map to 8 exons, and the exons have a similar distribution with respect to the protein coding sequences. Furthermore, the exons are distributed across the genomic DNA in a highly similar fashion. IO We have also compared the 5' flanking regions of the human and mouse genes to identify common features which may be important in transcriptional regulation of the genes. This comparison is shown in Fig 6, B and C. There is considerable similarity in exon 1 of human and mouse genes, and our identification of upstream transcription initiation sites for the human CD34 gene would suggest that mouse CD34 transcription starts 5' of the previously identified site.IO As identified in the human CD34 upstream sequences, we have likewise located 3 myb and 7 ets-like motifs in the published murine 5' flanking sequences.1° Two of these ets-like motifs were located in three homology domains found upstream of the genes (Fig 6C) , suggesting that the motifs may be important in CD34 regulation.
DISCUSSION
In this investigation, we isolated and characterized the human CD34 cDNA and genomic DNA sequences. In experiments not presented here, we have found that human CD34 cDNA sequences cross-hybridize to primate, rodent, avian, and canine, but not yeast genomic DNA. The conservation of the gene across species suggests an essential role for CD34. The extensive homology in the amino acid coding region between human and murine CD34 genes has previously been reported.IO Our data confirm these findings. Analysis of the amino acid sequences for the human and mouse CD34 genes has not provided a clear suggestion as to its function. However, the existence of cloned cDNAs for the genes should now enable determination of CD34 function. Our cloning of the complete human cDNA sequences and genomic DNA has enabled us to compare features of human and mouse CD34 genes that may control regulation of the gene.
Transcriptional regulation is determined both by promoter structure as well as the presence of DNA binding sites for regulatory proteins. Our data indicate that the human CD34 gene is a TATA-less gene that contains Spl DNA binding motifs and initiates transcription in a GC-rich region. The mouse CD34 promoter shares these features.l0 In addition, we have identified multiple transcription initiation sites for the human CD34 gene, a common finding for TATA-less promoters.20 These four features are usually associated with the promoters of constitutively expressed house-keeping genes.2O However, there is a group of developmentally regulated genes that shares these characteristics. The observed restricted expression of the human and mouse CD34 genes would appear to place them in this category of genes.10J1-23 The 5' terminus reported for the mouse cDNAI0 coincides with the 5' terminus of the human partial cDNA obtained by Seed et al. In 5'-RACE experiments, we identified two major clusters of 5' cDNA ends; the previously reported end lies in the region of our downstream termini. Our RNAase protection experiments indicate that these downstream termini either represent infrequently used transcription initiation sites or were products of interrupted reverse transcription.
Our analysis of the human CD34 upstream sequences has revealed the presence of myc, myb, and multiple ets-like motifs. We likewise identified 3 myb and 7 ets-like motifs in published murine 5' flanking sequences.I0 c-myc, c-myb, and the c-ets family of proteins have all been implicated to function as transcriptional activating proteins.18 The c-myb and c-myc proto-oncogenes play an essential role in normal hematopoietic d e v e l~p m e n t ,~~-~ and their expression is highest in CD34+ human hematopoietic cells.26 Therefore, these proteins may be involved in regulating CD34 expression. ets-like proteins have just recently been described in early hematopoietic cell linesz7 and the presence of numerous ets-like DNA binding motifs upstream of the human and mouse CD34 genes suggests that this family of transcriptional activators contributes to CD34 expression. This suggested role for c-myblc-ets in regulating CD34 gene expression is consistent with the induced ,acquisition of immature markers by hematopoietic cells expressing the oncogenic viral forms of myb or myb-ets fusion protein^.^,^^ This study should facilitate further investigations of the regulation of the CD34 gene. In future work we will seek to determine whether transcriptional activating oncoproteins regulate CD34 gene expression and perhaps also contribute to hematopoietic stem/progenitor cell malignancies. 
